Nantahala Capital Management’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Hold |
3,036,325
| – | – | 0.17% | 83 |
|
|
2025
Q1 | $3.95M | Hold |
3,036,325
| – | – | 0.16% | 70 |
|
|
2024
Q4 | $5.1M | Buy |
3,036,325
+2,525,252
| +494% | +$4.24M | 0.22% | 67 |
|
|
2024
Q3 | $986K | Hold |
511,073
| – | – | 0.05% | 97 |
|
|
2024
Q2 | $1.4M | Hold |
511,073
| – | – | 0.08% | 88 |
|
|
2024
Q1 | $1.47M | Hold |
511,073
| – | – | 0.08% | 81 |
|
|
2023
Q4 | $1.24M | Hold |
511,073
| – | – | 0.07% | 88 |
|
|
2023
Q3 | $1.56M | Hold |
511,073
| – | – | 0.13% | 81 |
|
|
2023
Q2 | $1.2M | Hold |
511,073
| – | – | 0.12% | 75 |
|
|
2023
Q1 | $1.48M | Hold |
511,073
| – | – | 0.11% | 72 |
|
|
2022
Q4 | $1.24M | Hold |
511,073
| – | – | 0.08% | 70 |
|
|
2022
Q3 | $1.43M | Buy |
+511,073
| New | +$1.43M | 0.09% | 69 |
|